Jasmin, Reyzon Raze C.

HRN: 23-15-85  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/19/2023
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
06/19/2023
06/26/2023
TOPICAL
1ml
TID
Oral Sores
Waiting Final Action 

Indication:  ProphylaxisEmpiric    Type of Infection:  Eye, Ear, Nose, Throat, & Mouth    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: